| HOME >> MEDICINE >> TECHNOLOGY |
40 PAIN MANAGEMENT THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
41 MARKETED THERAPIES FOR DIABETES
42 TOP FIVE ANTI-DIABETES PRODUCTS (2009)
43 DIABETES PREVALENCE BY GEOGRAPHY (2009)
44 DIABETES THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
45 TOP FIVE ONCOLOGY PRODUCTS (2009)
46 CANCER PREVALENCE, BY GEOGRAPHY (2009)
47 ONCOLOGY THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
48 MARKETED THERAPIES FOR RHEUMATOID ARTHRITIS
49 TOP FIVE ANTI RHEUMATIC PRODUCTS (2009)
50 RHEUMATOID ARTHRITIS PREVALENCE, BY GEOGRAPHY (2009)
51 RHEUMATOID ARTHRITIS THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
52 TOP FIVE ANTI-ANEMIA PRODUCTS (2009)
53 ANEMIA PREVALENCE, BY GEOGRAPHY (2009)
54 ANEMIA THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
55 TOP FIVE ANTI-HEPATITIS-C PRODUCTS (2009)
56 HEPATITIS-C PREVALENCE, BY GEOGRAPHY (2009)
57 HEPATITIS-C THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
58 CROHN'S DISEASE PREVALENCE, BY GEOGRAPHY (2009)
59 CROHN'S DISEASE THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
60 TOP FIVE ANTI-PSORIASIS PRODUCTS (2009)
61 PSORIASIS THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
62 PSORIASIS PREVALENCE, BY GEOGRAPHY (2009)
63 OTHER INJECDRUG DELIVERY THERAPEUTICS MARKET, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
64 AGREEMENTS & PARTNERSHIPS (2008 – 2010)
65 NEW PRODUCT LAUNCH (2008 – 2010)
66 EXPANSIONS (2008 – 2010)
67 REGULATORY APPROVALS (2008 – 2010)
68 MERGERS & ACQUISITIONS (2008 – 2010)
69 BAXTER BIOPHARMA - TOTAL REVENUES & R&D EXPENSES ($MILLION)
70
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |